ARTN: A Potential Drug Target for Various Diseases (G9048)

Target Name: ARTN

NCBI ID: G9048

ARTN

ARTN: A Potential Drug Target for Various Diseases

ARTN, also known as Transcript variant 4 (Tv4), is a gene that encodes a protein known as arteminin. Arteminin is a highly conserved protein that is found in various organisms, including humans. It is involved in a wide range of cellular processes, including cell signaling, DNA replication, and stress response.

Recent studies have identified ARTN as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The high conservation nature of the protein makes it an attractive target for drug development due to the potential for minimal side effects.

One of the key reasons for the potential of ARTN as a drug target is its involvement in a wide range of cellular processes. The protein is involved in the regulation of cell signaling pathways, which are critical for the development and progression of various diseases. For example, ARTN has been shown to be involved in the regulation of cell proliferation, apoptosis (programmed cell death), and cell migration.

In addition to its involvement in cellular processes, ARTN has also been shown to play a role in the regulation of DNA replication. This is important for the development and progression of cancer, as changes in DNA replication can contribute to the development of cancer cells.

Another potential mechanism by which ARTN may contribute to the development of cancer is its role in stress response. ARTN has been shown to be involved in the regulation of cellular stress responses, which are critical for the survival of cells under stress. This is important for the development and progression of cancer, as cellular stress responses can contribute to the development of cancer cells.

In addition to its potential role in cancer, ARTN has also been shown to be involved in the development and progression of neurodegenerative diseases. This is important for the development of new treatments for these diseases, which are often difficult to treat.

Overall, the potential of ARTN as a drug target is due to its involvement in a wide range of cellular processes that are important for the development and progression of various diseases. As research continues to progress, the potential of ARTN as a drug target for cancer, neurodegenerative diseases, and other conditions will continue to be explored.

Protein Name: Artemin

Functions: Ligand for the GFR-alpha-3-RET receptor complex but can also activate the GFR-alpha-1-RET receptor complex. Supports the survival of sensory and sympathetic peripheral neurons in culture and also supports the survival of dopaminergic neurons of the ventral mid-brain. Strong attractant of gut hematopoietic cells thus promoting the formation Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue

The "ARTN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARTN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets